Let’s Work
Together
To Translate Causal Biology Into Real-World Therapies.
The Tangible Result
01Collaborating to Reprogram Disease Faster
We believe true innovation happens at the intersection of deep biology and bold collaboration. We’re partnering with leaders in disease biology and modality innovation to translate causal insights from the regulatory genome into life-changing RNA medicines.
A Testament to our Forward-Thinking ApproachÂ
02HAYA and Lilly Join Forces
A multi-year collaboration focused on identifying multiple regulatory genome derived RNA-based drug targets to address obesity and related metabolic diseases.
Become a Partner
03Interested in
Collaborating
with Us?
Our team is ready to start the conversation, and explore the next steps to redefine medicine together.